NICE has approved Merck Sharp & Dohme and Schering-Plough's Ezetrol, but recommended the cheapest version be used – effectively blocking …
Schering-Plough and Merck have announced plans to develop a new 2-in-1 cholesterol pill that would include Lipitor, which belongs to …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

